Activation of GSK3 Prevents Termination of TNF-Induced Signaling

References

• Buckley CD, Gilroy DW, Serhan CN, Stockinger B, Tak PP. The resolution of inflammation. Nat Rev Immunol. 2013;13(1):59–66. doi:10.1038/nri3362
   PubMed Web of Science ®Google Scholar
• Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov. 2016;15:551–567.
   PubMed Web of Science ®Google Scholar
• Nathan C, Ding A. Nonresolving inflammation. Cell. 2010;140:871–882.
   PubMed Web of Science ®Google Scholar
• Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13:759–771.
   PubMed Web of Science ®Google Scholar
• Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. Resolution of inflammation: what controls its onset? Front Immunol. 2016;7:160.
   PubMed Web of Science ®Google Scholar
• Chen Z, Bozec A, Ramming A, Schett G. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol. 2019;15:9–17.
   PubMed Web of Science ®Google Scholar
• Soto-Heredero G, Gomez de Las Heras MM, Gabande-Rodriguez E, Oller J, Mittelbrunn M. Glycolysis - a key player in the inflammatory response. FEBS J. 2020;287:3350–3369.
   PubMed Web of Science ®Google Scholar
• Boada-Romero E, Martinez J, Heckmann BL, Green DR. The clearance of dead cells by efferocytosis. Nat Rev Mol Cell Biol. 2020;21:398–414.
   PubMed Web of Science ®Google Scholar
• Gause WC, Rothlin C, Loke P. Heterogeneity in the initiation, development and function of type 2 immunity. Nat Rev Immunol. 2020;20:603–614.
   PubMed Web of Science ®Google Scholar
• Huber R, Bikker R, Welz B, Christmann M, Brand K. TNF tolerance in monocytes and macrophages: characteristics and molecular mechanisms. J Immunol Res. 2017;2017:9570129. doi:10.1155/2017/9570129
   PubMed Web of Science ®Google Scholar
• Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16:531–543.
   PubMed Web of Science ®Google Scholar
• Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12:49–62.
   PubMed Web of Science ®Google Scholar
• Brenner D, Blaser H, Mak TW. Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol. 2015;15:362–374.
   PubMed Web of Science ®Google Scholar
• Vereecke L, Beyaert R, van Loo G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 2009;30:383–391.
   PubMed Web of Science ®Google Scholar
• Bikker R, Christmann M, Preuss K, et al. TNF phase III signalling in tolerant cells is tightly controlled by A20 and CYLD. Cell Signal. 2017;37:123–135.
   PubMed Web of Science ®Google Scholar
• Park SH, Park-Min KH, Chen J, Hu X, Ivashkiv LB. Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages. Nat Immunol. 2011;12:607–615.
   PubMed Web of Science ®Google Scholar
• Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693–733.
   PubMed Web of Science ®Google Scholar
• Gunther J, Vogt N, Hampel K, et al. Identification of two forms of TNF tolerance in human monocytes: differential inhibition of NF-kappaB/AP-1- and PP1-associated signaling. J Immunol. 2014;192:3143–3155.
   PubMed Web of Science ®Google Scholar
• Zwergal A, Quirling M, Saugel B, et al. C/EBP beta blocks p65 phosphorylation and thereby NF-kappa B-mediated transcription in TNF-tolerant cells. J Immunol. 2006;177:665–672.
   PubMed Web of Science ®Google Scholar
• Welz B, Bikker R, Junemann J, et al. Proteome and phosphoproteome analysis in TNF long term-exposed primary human monocytes. Int J Mol Sci. 2019;20:e1241.
   PubMed Web of Science ®Google Scholar
• Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature. 2000;406:86–90.
   PubMed Web of Science ®Google Scholar
• Cohen P, Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol. 2001;2:769–776.
   PubMed Web of Science ®Google Scholar
• Piazzi M, Bavelloni A, Faenza I, Blalock W. Glycogen synthase kinase (GSK)-3 and the double-strand RNA-dependent kinase, PKR: when two kinases for the common good turn bad. Biochim Biophys Acta Mol Cell Res. 2020;1867:118769.
   PubMed Web of Science ®Google Scholar
• Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378:785–789.
   PubMed Web of Science ®Google Scholar
• Harwood AJ. Regulation of GSK-3: a cellular multiprocessor. Cell. 2001;105:821–824.
   PubMed Web of Science ®Google Scholar
• Hoffmeister L, Diekmann M, Brand K, Huber R. GSK3: a kinase balancing promotion and resolution of inflammation. Cells. 2020;9:820.
   PubMed Web of Science ®Google Scholar
• Huber R, Panterodt T, Welz B, et al. C/EBPbeta-LAP*/LAP expression is mediated by RSK/eIF4B-Dependent signalling and boosted by increased protein stability in models of monocytic differentiation. PLoS One. 2015;10:e0144338.
   PubMedGoogle Scholar
• Haas SC, Huber R, Gutsch R, et al. ITD- and FL-induced FLT3 signal transduction leads to increased C/EBPbeta-LIP expression and LIP/LAP ratio by different signalling modules. Br J Haematol. 2010;148:777–790.
   PubMed Web of Science ®Google Scholar
• Cappello C, Zwergal A, Kanclerski S, et al. C/EBPbeta enhances NF-kappaB-associated signalling by reducing the level of IkappaB-alpha. Cell Signal. 2009;21:1918–1924.
   PubMed Web of Science ®Google Scholar
• Robertson H, Hayes JD, Sutherland C. A partnership with the proteasome; the destructive nature of GSK3. Biochem Pharmacol. 2018;147:77–92.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol. 2008;8:837–848.
   PubMed Web of Science ®Google Scholar
• Brasier AR, Lu M, Hai T, Lu Y, Boldogh I. NF-kappa B-inducible BCL-3 expression is an autoregulatory loop controlling nuclear p50/NF-kappa B1 residence. J Biol Chem. 2001;276:32080–32093.
   PubMed Web of Science ®Google Scholar
• Wilson W 3rd, Baldwin AS. Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer. Cancer Res. 2008;68:8156–8163.
   PubMed Web of Science ®Google Scholar
• Chang TP, Vancurova I. Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphoma. Biochim Biophys Acta. 2014;1843:2620–2630.
   PubMed Web of Science ®Google Scholar
• Lee RE, Walker SR, Savery K, Frank DA, Gaudet S. Fold change of nuclear NF-kappaB determines TNF-induced transcription in single cells. Mol Cell. 2014;53:867–879.
   PubMed Web of Science ®Google Scholar
• Huang HL, Yeh WC, Lai MZ, et al. Impaired TNFalpha-induced A20 expression in E1A/Ras-transformed cells. Br J Cancer. 2009;101:1555–1564.
   PubMed Web of Science ®Google Scholar
• Harmonizome. BCL3 ENCODE and transcription factor targets. Available from: https://maayanlab.cloud/Harmonizome/gene_set/BCL3/ENCODE+Transcription+Factor+Targets. Accessed April 15, 2020.
   Google Scholar
• Rouillard AD, Gundersen GW, Fernandez NF, et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database. 2016;2016:baw100.
   Google Scholar
• Kaidanovich-Beilin O, Woodgett JR. GSK-3: functional insights from cell biology and animal models. Front Mol Neurosci. 2011;4:40.
   PubMed Web of Science ®Google Scholar
• Beurel E, Grieco SF, Jope RS. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther. 2015;148:114–131.
   PubMed Web of Science ®Google Scholar
• Huang A, Patel S, McAlpine CS, Werstuck GH. The role of endoplasmic reticulum stress-glycogen synthase kinase-3 signaling in atherogenesis. Int J Mol Sci. 2018;19:1607.
   PubMed Web of Science ®Google Scholar
• Cormier KW, Woodgett JR. Recent advances in understanding the cellular roles of GSK-3. F1000Res. 2017;6:167.
   Google Scholar
• Tullai JW, Graham JR, Cooper GM. A GSK-3-mediated transcriptional network maintains repression of immediate early genes in quiescent cells. Cell Cycle. 2011;10:3072–3077.
   PubMed Web of Science ®Google Scholar
• Graham JR, Tullai JW, Cooper GM. GSK-3 represses growth factor-inducible genes by inhibiting NF-kappaB in quiescent cells. J Biol Chem. 2010;285:4472–4480.
   PubMed Web of Science ®Google Scholar
• Johnson A. TNF-induced activation of pulmonary microvessel endothelial cells: a role for GSK3beta. Am J Physiol Lung Cell Mol Physiol. 2009;296:L700–709.
   PubMed Web of Science ®Google Scholar
• Yoon K, Jung EJ, Lee SR, Kim J, Choi Y, Lee SY. TRAF6 deficiency promotes TNF-induced cell death through inactivation of GSK3beta. Cell Death Differ. 2008;15:730–738.
   PubMed Web of Science ®Google Scholar
• Oguma K, Oshima H, Aoki M, et al. Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J. 2008;27:1671–1681.
   PubMed Web of Science ®Google Scholar
• Mackay HJ, Twelves CJ. Targeting the protein kinase C family: are we there yet? Nat Rev Cancer. 2007;7:554–562.
   PubMed Web of Science ®Google Scholar
• Lei S, Su W, Liu H, et al. Nitroglycerine-induced nitrate tolerance compromises propofol protection of the endothelial cells against TNF-alpha: the role of PKC-beta2 and NADPH oxidase. Oxid Med Cell Longev. 2013;2013:678484.
   PubMed Web of Science ®Google Scholar
• Rosenzweig T, Braiman L, Bak A, Alt A, Kuroki T, Sampson SR. Differential effects of tumor necrosis factor-alpha on protein kinase C isoforms alpha and delta mediate inhibition of insulin receptor signaling. Diabetes. 2002; 51:1921–1930.
   PubMed Web of Science ®Google Scholar
• Schutze S, Nottrott S, Pfizenmaier K, Kronke M. Tumor necrosis factor signal transduction. Cell-type-specific activation and translocation of protein kinase C. J Immunol. 1990;144:2604–2608.
   PubMed Web of Science ®Google Scholar
• Muller N, Schneider B, Pfizenmaier K, Wajant H. Superior serum half life of albumin tagged TNF ligands. Biochem Biophys Res Commun. 2010;396:793–799.
   PubMed Web of Science ®Google Scholar
• Omura S, Asami Y, Crump A. Staurosporine: new lease of life for parent compound of today’s novel and highly successful anti-cancer drugs. J Antibiot. 2018;71:688–701.
   PubMed Web of Science ®Google Scholar
• Mochly-Rosen D, Das K, Grimes KV. Protein kinase C, an elusive therapeutic target? Nat Rev Drug Discov. 2012;11:937–957.
   PubMed Web of Science ®Google Scholar
• Mattmann ME, Stoops SL, Lindsley CW. Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape. Expert Opin Ther Pat. 2011;21:1309–1338.
   PubMed Web of Science ®Google Scholar
• Diaz-Velasquez CE, Castro-Munozledo F, Kuri-Harcuch W. Staurosporine rapidly commits 3T3-F442A cells to the formation of adipocytes by activation of GSK-3beta and mobilization of calcium. J Cell Biochem. 2008;105:147–157.
   PubMed Web of Science ®Google Scholar
• Hornstein T, Lehmann S, Philipp D, et al. Staurosporine resistance in inflammatory neutrophils is associated with the inhibition of caspase- and proteasome-mediated Mcl-1 degradation. J Leukoc Biol. 2016;99:163–174.
   PubMed Web of Science ®Google Scholar
• Steinbrecher KA, Wilson W 3rd, Cogswell PC, Baldwin AS. Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription. Mol Cell Biol. 2005;25:8444–8455.
   PubMed Web of Science ®Google Scholar
• Wessells J, Baer M, Young HA, et al. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J Biol Chem. 2004;279:49995–50003.
   PubMed Web of Science ®Google Scholar
• Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226:205–218.
   PubMed Web of Science ®Google Scholar
• Carmody RJ, Ruan Q, Palmer S, Hilliard B, Chen YH. Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. Science. 2007;317:675–678.
   PubMed Web of Science ®Google Scholar
• Mbongue JC, Nicholas DA, Torrez TW, Kim NS, Firek AF, Langridge WH. The role of indoleamine 2, 3-dioxygenase in immune suppression and autoimmunity. Vaccines. 2015;3:703–729.
   PubMed Web of Science ®Google Scholar
• Park BH, Qiang L, Farmer SR. Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Mol Cell Biol. 2004;24:8671–8680.
   PubMed Web of Science ®Google Scholar
• Moutal A, White KA, Chefdeville A, et al. Dysregulation of CRMP2 post-translational modifications drive its pathological functions. Mol Neurobiol. 2019;56:6736–6755.
   PubMed Web of Science ®Google Scholar
• Khanna R, Moutal A, Perez-Miller S, Chefdeville A, Boinon L, Patek M. Druggability of CRMP2 for neurodegenerative diseases. ACS Chem Neurosci. 2020;11:2492–2505.
   PubMed Web of Science ®Google Scholar